Skip to content

Peri-operative Vasopressor Support in Patients Operated for an Acute Hip Fracture (AHF)

Peri-operative Vasopressor Support in Patients Operated for an Acute Hip Fracture (AHF)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03497949
Enrollment
997
Registered
2018-04-13
Start date
2017-01-20
Completion date
2018-03-31
Last updated
2026-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fractures, Intraoperative Hypotension

Brief summary

The incidence of hypotension perioperatively during operation of an acute hip fracture is unknown. As a surrogate factor the usage of vasopressor support is more adequate as the registration of vasopressor drugs are many times not complete in records. The investigators retrospectively investigated the anesthetic journals of 1100 patients with an acute hip fracture (AHF) noting confounding factors and the usage of vasopressors either by injections or infusions and then correlated these results to mortality at 30-, 90- and 365- days

Detailed description

The incidence of hypotension perioperatively during operation of an acute hip fracture is unknown. As a surrogate factor the usage of vasopressor support is more adequate as the registration of vasopressor drugs are many times not complete in records. The investigators retrospectively investigated the anesthetic journals of 1100 patients with an acute hip fracture (AHF) noting confounding factors and the usage of vasopressors either by injections or infusions and then correlated these results to mortality at 30-, 90- and 365-days Confounding factors were; all comorbitity, age, ASA grade as well as type of anesthesia

Interventions

None listed

Sponsors

Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with an acute hip fracture

Exclusion criteria

* Only one fracture within time-limit. * Unretreivable mortality data

Design outcomes

Primary

MeasureTime frame
Mortality365 days

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 2, 2026